Privacy settings

We use technical cookies, that are necessary for the management of the website, statistical cookies and marketing cookies (including third parties cookies) for displaying individual offers and ads. For more information read our Privacy Policy. Statistical cookies and marketing cookies (inclusive of third parties cookies) are used only with your consent. By clicking “Select all and agree” you consent to our use of statistical and/or marketing cookies (inclusive of third parties cookies).

To customize your privacy settings, tick your preferences in the checkboxes and click “Apply selection”. You can always change the privacy settings and deactivate cookies by following the instructions in the Privacy Policy.

Show preferences Select all and accept
IMA is loading

Main Financial Data 2015

Main Data: 31/12 Year 2015
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 1,109.54
– gross industrial income 420.77
– total operating cost 305.15
– operating profit 115.62
– net financial expenses 1.04
– profit attributable to equity holders of the parent 69.92

 

 

Consolidated balance sheet Millions/Euro
– working capital 13.99
– non-current assets 420.00
– provision for severance indemnities and other provisions – 95.09
– net debt – 163.12
– equity pertaining to the group and minority interests 175.78

 

Other information  Millions/Euro
– depreciation, amortization and impairment 32.52
– R & D costs 40.05

 

  Euro
Dividend per share 1.35

 

  No.
Employees 4,576

 

  Euro
Share capital 19,505,200

 

Main Data: 30/06 Year 2015
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 481.2
– gross industrial income 182.2
– total operating cost 151.0
– operating profit 31.2
– net financial expenses 9.7
– profit attributable to equity holders of the parent 11.4

 

Consolidated balance sheet Millions/Euro
– working capital 37.1
– non-current assets 428.0
– provision for severance indemnities and other provisions – 96.7
– net debt – 255.3
– equity pertaining to the group and minority interests  113.1

 

Other information Millions/Euro
– depreciation, amortization and impairment 14.3
– R & D costs 19.9

 

  No.
Employees 4,392

 

  Euro
Share Capital 19,505,200

 

Net Sales by Sector: Year 2015
  Millions/Euro  
tea, food & other 590.46 53.2%
pharmaceutical 519.08 46.8%
Total 1,109.54 100.0%

 

Net Sales by Country: Year 2015
  Millions/Euro  
E.U. (excluding Italy) 352.71 31.8%
Other European countries 68.89 6.2%
North America 223.42 20.1%
Asia & Middle East 227.77 20.5%
Other countries 118.26 10.7%
Total exports 991.05 89.3%
Italy 118.49 10.7%
Total 1,109.54 100.0%